AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Fenofibrate in South Africa
6 products registered with SAHPRA — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| FENOGLO | 56/7.5/0614.613 | Austell Pharmaceuticals (Pty) Ltd | active | 12 Mar 2029 |
| LIPFENO | 56/7.5/0613 | Austell Pharmaceuticals (Pty) Ltd | active | 12 Mar 2029 |
| LIPANTHYL 145 mg | 56/7.5/0113 | Abbott Laboratories S.A. (Pty) Ltd | active | 12 Mar 2029 |
| LIPANTHYL 160 mg | 41/7.5/0556 | Abbott Laboratories S.A. (Pty) Ltd | active | 1 Jan 1900 |
| LIPANTHYL 200 mg | 30/7.5/0494 | Abbott Laboratories S.A. (Pty) Ltd | active | 1 Jan 1900 |
| TRICOR 160 mg | 41/7.5/0848 | Abbott Laboratories S.A. (Pty) Ltd | active | 1 Jan 1900 |
Fenofibrate — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Fenofibrate, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Fenofibrate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.